Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05841082
Other study ID # CRUISE-2020-12-28
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date January 1, 2015
Est. completion date June 30, 2024

Study information

Verified date May 2023
Source China-Japan Friendship Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Coronary artery disease (CAD) is the leading cause of death in end-stage renal disease (ESRD) patients requiring dialysis. There are limited data on clinical characteristics, treatment strategies and outcomes in this special patient population in China. As a nationwide, observational, multicenter cohort study, this study consecutively included ESRD patients on dialysis with significant CAD at 30 tertiary care centers in 12 provinces in China from January 2015 to June 2021. Patient data collected included demographics, comorbidities, cardiac history, cardiac function, location and severity of CAD, procedural information, medications, and clinical events.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1249
Est. completion date June 30, 2024
Est. primary completion date June 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 50% or greater stenosis in any of three main coronary arteries or left main coronary artery on visual assessment of the coronary angiogram - Receive peritoneal dialysis or hemodialysis for more than 3 months Exclusion Criteria: -

Study Design


Locations

Country Name City State
China China-Japan Friendship Hospital Beijing Beijing

Sponsors (30)

Lead Sponsor Collaborator
China-Japan Friendship Hospital Aerospace Center Hospital, Beijing Chao Yang Hospital, Cangzhou Central Hospital of Tianjin Medical University, Civil Aviation General Hospital, Dongguan Tungwah Hospital, Emergency General Hospital, Fifth Affiliated Hospital of Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University, First Central Hospital of Tianjin, Fuwai Yunnan Cardiovascular Hospital, Guangdong Provincial People's Hospital, Henan Provincial Chest Hospital, Ningbo No. 1 Hospital, Peking University People's Hospital, Peking University Shougang Hospital, People's Hospital of Guangxi, People's Hospital of Xinjiang Uygur Autonomous Region, Second Hospital of Tianjin Medical University, Shaoxing People's Hospital, Shengjing Hospital, the First Affiliated Hospital, Harbin Medical University, The Third People's Hospital of Chengdu, Tianjin Medical University General Hospital, Tianjin Union Medicine Center, Tongji Hospital, West China Hospital, Wuhan University, Xuanwu Hospital, Beijing, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary All-cause death All-cause deaths include cardiovascular death and non-cardiovascular death. Cardiovascular death is defined as death due to acute myocardial infarction, heart failure, sudden cardiac death, stroke, cardiovascular procedure, or cardiovascular hemorrhage. Non-cardiovascular death: any death not covered by the above definitions, such as death caused by infection, malignancy, sepsis, pulmonary causes, accident, suicide, or trauma. 12-month follow-up
Secondary Major adverse cardiovascular events A composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. From the hospital admission to 12-month follow-up
Secondary Major or clinically relevant nonmajor bleeding A bleeding event meeting Bleeding Academic Research Consortium criteria type 2, 3, or 5. From the hospital admission to 12-month follow-up
Secondary Cardiovascular death Cardiovascular death is defined as death due to acute myocardial infarction, heart failure, sudden cardiac death, stroke, cardiovascular procedure, or cardiovascular hemorrhage. From the hospital admission to 12-month follow-up
Secondary Non-fatal myocardial infarction Non-fatal myocardial infarction is confirmed in patients with ischemic symptoms, elevated serum cardiac biomarkers and/or distinctive ECG changes. From the hospital admission to 12-month follow-up
Secondary Non-fatal myocardial stroke Non-fatal myocardial stroke is confirmed as a new neurological deficit attributed to a vascular cause in the central nervous system with imaging evidence by computed tomography or magnetic resonance imaging. From the hospital admission to 12-month follow-up
Secondary Major bleeding A bleeding event meeting Bleeding Academic Research Consortium criteria type 3, or 5. From the hospital admission to 12-month follow-up
Secondary Clinically relevant nonmajor bleeding A bleeding event meeting Bleeding Academic Research Consortium criteria type 2. From the hospital admission to 12-month follow-up
Secondary Follow-up major adverse cardiovascular and clinical events We will follow up the patients by telephone and outpatient service to know the all-cause mortality (cardiovascular and non-cardiovascular) and cardiovascular events. From the hospital admission, and up to 10 years
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A